Institutional Investor Files Intent to Sell $9.38M in Hinge Health Shares
summarizeSummary
Bessemer Venture Partners X Institutional LP, an institutional investor and director, filed a Form 144 indicating intent to sell 242,100 shares of Hinge Health, valued at approximately $9.38 million. This follows over $41 million in sales by related entities in the past three months, signaling a sustained liquidation.
check_boxKey Events
-
Proposed Share Sale
Bessemer Venture Partners X Institutional LP intends to sell 242,100 Class A shares, valued at approximately $9.38 million, on or around February 12, 2026.
-
Ongoing Liquidation
This proposed sale follows over $41 million in sales by related Bessemer entities in the past three months, indicating a sustained reduction in their investment in Hinge Health.
-
Institutional Investor Disposition
The filer is an institutional investor with a director relationship to Hinge Health, suggesting portfolio rebalancing as a primary driver for the disposition, though the cumulative size is notable.
auto_awesomeAnalysis
This Form 144 filing signals a continued liquidation of shares by Bessemer Venture Partners X Institutional LP, an institutional investor with a director relationship to the company. The proposed sale of 242,100 shares, valued at approximately $9.38 million, adds to over $41 million in sales by related Bessemer entities over the last three months. This sustained reduction in their stake, totaling over $50 million in recent and proposed sales, represents a significant disposition by a major investor and could create an overhang on the stock, potentially impacting investor sentiment despite the company's recent positive Q4 earnings report.
At the time of this filing, HNGE was trading at $39.85 on NYSE in the Technology sector, with a market capitalization of approximately $3.1B. The 52-week trading range was $30.08 to $62.18. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.